November 01, 2013
1 min read
Save

Metabolic parameters, 25(OH)D levels inversely related among psoriatic patients without arthritis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Psoriatic patients without arthritis displayed an inverse correlation between 25-hydroxyvitamin D levels and lipid and metabolic parameters, while patients with arthritis did not, according to recent study data.

In a cross-sectional study researchers recruited 122 matched patients with psoriasis from dermatology and rheumatology departments at a hospital in Granada, Spain. Patients were categorized as patients without arthritis (n=61) and those with arthritis (n=61) and evaluated for lipid and metabolic variables, along with 25-hydroxyvitamin D (serum 25[OH]D) levels. Serum 25(OH)D levels were measured within a 2-month window to minimize seasonal variations.

Among the patients without arthritis, researchers observed inverse relationships between 25(OH)D levels and low-density lipoproteins (r=–0.415; P=.001), total cholesterol (r=–0.440; P=.000), total cholesterol/high-density lipoprotein (HDL; r=–0.303; P=.01), fasting glucose (r=–0.285; P=.026) and triglycerides (r=–0.280; P=.029). No correlation with HDL was found (r=–0.006; P=.962). All metabolic parameters except triglycerides and total cholesterol/HDL remained statistically significant under multivariate analysis.

There were no associations detected between metabolic parameters and 25(OH)D levels in patients with psoriatic arthritis.

“Low levels of vitamin D in psoriatic patients without arthritis were associated with high levels of total cholesterol, LDL, total cholesterol/HDL, triglycerides, and glycemia,” the researchers concluded. “These associations were not observed in psoriatic patients with arthritis. Interventional studies with vitamin-D supplementation are required to verify these metabolic benefits in psoriatic patients without arthritis.”

Disclosure: The researchers report no relevant financial disclosures.